AVROBIO (AVRO) Peer Comparison

$1.45

$-15.59 (-91.49%)

As on 20-Jun-2024 17:53EDT

Market cap

$5 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

0.2

P/B Ratio

0.6

Div. Yield

0 %

Edit

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Market cap ($ Mln)	5	0
Revenue ($ Mln)	4	--
Net Profit ($ Mln)	30.31	--
Net Margin (%)	842.30	--
RoE (%)	31.62	--
Price to Earnings	0.17	--
Price-To-Book	0.60	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Operating Revenue	3.60	0.00
Cost of Revenue	2.68	--
Gross Profit	-0.62	--
Operating Expenses	54.06	9.93
Operating Profit (EBIT)	27.83	-9.93
Other Income	0.00	--
Profit before Tax	30.68	-9.29
Provision for Tax	-2.57	--
Profit after Tax (Net Income)	30.31	-9.29
Minority Interest	0.00	--
Consolidated Profit	67.48	--

Liabilities ($ Mln)

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Shareholder's Funds	88.84	9.54
Minority Interest	0.00	--
Non-Current Liabilities	0.00	0.10
Current Liabilities	3.51	0.72
Total Liabilities	101.09	13.04

Assets ($ Mln)

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Non-Current Assets	0.51	2.17
Current Assets	91.84	8.19
Total Assets	101.09	--
Total Debt*	0.22	0.00
Net Current Assets	88.33	7.47

Cashflow ($ Mln)

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Cash From Operating Activities	-63.19	-8.21
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	-16.03	0.57
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
ROCE (%)	12.90	-59.51
ROE (%)	31.62	-59.63
ROA (%)	31.81	-55.51
EBIT Margin (%)	-1,439.53	--
Net Margin (%)	842.30	--
Cash Profit Margin (%)	0.00	--

Growth Ratios

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Revenue Growth (%)	--	--
EBIT Growth (%)	49.17	--
Net Profit Growth (%)	170.93	5.92
EPS Growth (%)	--	--
Book Value Growth (%)	--	--

Valuation Ratios

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Price / Earnings	--	--
Price / Book Value	--	--
Dividend Yield (%)	--	--
EV/EBITDA	1.37	--
Market Cap ($ Cr)	--	--

Solvency Ratios

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.00	0.00
Current Ratio	26.17	11.36
Quick Ratio	26.17	11.36
Interest Coverage	15.13	--

Operating Efficiency Ratios

	AVROBIO (AVRO)	Artelo Biosciences Inc. Warrant (ARTLW)
Debtors to sales (%)	0.00	--
Asset Turnover	0.04	0.00
Receivable days	--	--
Inventory Days	-159.24	--
Payable days	121.65	--
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly